Jan. 8, 2025 — ScreenPoint Medical has acquiredf Biomediq A/S, a research-based company focused on the research, development and implementation of quantitative imaging biomarkers. After a decade of close collaboration as separate entities on image based risk assessment, this deal is expected to bring breast cancer risk assessment capabilities to ScreenPoint's  Breast AI, Transpara.

Jan. 8, 2025 - EDAP TMS SA, a supplier of robotic energy-based therapies, has announced that the first patient has been treated in a phase I/II PULS Trial sponsored by the Centre Léon Bérard, Lyon, France, evaluating proprietary High Intensity Focused Ultrasound (HIFU) technology for the treatment of pancreatic tumors.

Computed tomography (CT) has long been a cornerstone of modern imaging, providing detailed 3D insights into the human body and other materials. However, conventional CT requires hundreds of X-ray projections from multiple angles, exposing patients to significant radiation doses and relying on large, immobile systems.

Dec. 13, 2024 — A recent study by the Harvey L. Neiman Health Policy Institute demonstrates that mobile mammography is generally used by women otherwise unlikely to be screened, and thus is complementary to facility-based mammography rather than a substitute for it. Hence, mobile mammography could feasibly increase breast cancer screening rates, especially in traditionally underserved communities.

Dec. 18, 2024 – Accuray Inc. recently announced an international retrospective multicenter analysis found that radiosurgery (SRS) and fractionated stereotactic radiotherapy (FSRT), delivered with the CyberKnife System, can provide an effective and time-saving treatment option for brainstem metastases (BSM). The nine institution study results, published in the International Journal of Cancer, “underscore the long- term benefits in local control and the robust safety profile despite the delicate location of the treated metastases.1”

Dec. 12, 2024 — RIVANNA  has released a report that details significant regional demand for anesthesiologists while also examining the rapid growth of the diagnostic ultrasound market, a development influenced by technological advancements and evolving healthcare needs.

Dec. 12, 2024 — At RSNA 2024, Careverse officially made its debut, exhibiting in the AI Showcase area, sharing its innovative achievements in multimodal imaging AI and large language models with medical experts and scientists from around the world.

Careverse is committed to empowering a new era of smart healthcare by creating an AI-powered Digital Doctor which assists human doctors to deliver much more efficient, accurate, consistent and accessible patient care.

Dec. 17, 2024 — Radin Health, a provider of advanced radiology AI-Powered solutions, highlighted its All-in-One Radiology Workflow Management Solution at RSNA '24 in Chicago, IL.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now